Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in

Nathalie Saidenberg-Kermanac'h1, Natacha Bessis, Delphine Lemeiter

  • 1UPRES EA-3408 and Department of Rheumatology, Avicenne Hospital (AP-HP), Bobigny Medical School, Paris 13 University, France.

Journal of Clinical Immunology
|May 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the target: implications of Wnt pathway inhibitors on bone health.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Correction: Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping Review.

Advances in therapy·2026
Same author

Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping Review.

Advances in therapy·2026
Same author

Impact of JAK-inhibition on pain and biphasic P2X7R expression on CD4<sup>+</sup> T cells in experimental arthritis.

Scientific reports·2026
Same author

From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy.

Bone research·2026
Same author

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

JAMA·2026

Interleukin-4 (IL-4) and Osteoprotegerin (OPG) treatments improved collagen-induced arthritis (CIA) in mice. Combined therapy enhanced bone density and reduced bone resorption markers, suggesting a potent therapeutic strategy for inflammatory bone loss.

Area of Science:

  • Immunology
  • Rheumatology
  • Bone Biology

Background:

  • Collagen-induced arthritis (CIA) is a mouse model for rheumatoid arthritis, characterized by inflammation and bone resorption.
  • Interleukin-4 (IL-4) is an anti-inflammatory cytokine, while Osteoprotegerin (OPG) inhibits bone resorption.
  • The combined therapeutic potential of IL-4 and OPG in CIA is not fully understood.

Purpose of the Study:

  • To investigate the individual and combined effects of IL-4 and OPG on the inflammatory process in CIA.
  • To evaluate their impact on associated bone resorption and bone mineral density (BMD) in the CIA model.

Main Methods:

  • DBA/1 mice were induced with CIA and subsequently treated with OPG, IL-4, or a combination of both.
  • Arthritis severity was assessed using clinical and histological scores.

Related Experiment Videos

  • Bone mineral density (BMD) and bone resorption markers (D-pyridinolin) were measured. Interferon-gamma (IFN-gamma) production was analyzed.

    • Main Results:

    • IL-4 significantly improved CIA clinical scores. OPG alone did not affect clinical scores but reduced histological scores.
    • Both OPG and IL-4, individually and in combination, reduced histological scores compared to untreated CIA mice.
    • OPG significantly increased BMD and decreased D-pyridinolin levels. The combination therapy showed additive effects on BMD and resorption markers.
    • IL-4 reduced IFN-gamma production; OPG had a moderate effect but potentiated IL-4's inhibitory action.

    Conclusions:

    • Both IL-4 and OPG demonstrate therapeutic potential in preventing bone loss in the CIA mouse model.
    • Combined IL-4 and OPG treatment exhibits additive benefits in preserving bone mineral density and reducing bone resorption.
    • The combination therapy may also synergistically modulate immune responses, specifically reducing IFN-gamma secretion.